Innovative Clinical Research, Inc.

Hialeah, Florida 33012

0 studies enrolling now · 4 studies all time

What they study most

Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant, Insomnia Disorder, Treatment Resistant Depression

Studies at this site

• Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDD — Completed
• Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia Disorder — Completed
• A Study of Rapastinel for Rapid Treatment of Depression and Suicidality in Major Depressive Disorder — Stopped early
• Safety, Tolerability, PK and Efficacy of Single Doses of NV-5138 in Healthy Volunteers and Subjects With Treatment-Resistant Depression — Completed